104 related articles for article (PubMed ID: 3099185)
1. Aflatoxin B1 activation to a plasmid mutagen by a chemical model of cytochrome P-450.
Wood ML; Smith JR; Garner RC
Mutat Res; 1987 Jan; 176(1):11-20. PubMed ID: 3099185
[TBL] [Abstract][Full Text] [Related]
2. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
3. Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses.
Baertschi SW; Raney KD; Shimada T; Harris TM; Guengerich FP
Chem Res Toxicol; 1989; 2(2):114-2. PubMed ID: 2519710
[TBL] [Abstract][Full Text] [Related]
4. The reactivity and carcinogenicity of aflatoxin B1-2,3-dichloride, a model for the putative 2,3-oxide metabolite of aflatoxin B1.
Swenson DH; Miller JA; Miller EC
Cancer Res; 1975 Dec; 35(12):3811-23. PubMed ID: 1104159
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis.
San RH; Chan RI
Mutat Res; 1987 Apr; 177(2):229-39. PubMed ID: 3104775
[TBL] [Abstract][Full Text] [Related]
6. The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes.
Takahashi N; Harttig U; Williams DE; Bailey GS
Carcinogenesis; 1996 Jan; 17(1):79-87. PubMed ID: 8565141
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive properties of chlorophyllin: inhibition of aflatoxin B1 (AFB1)-DNA binding in vivo and anti-mutagenic activity against AFB1 and two heterocyclic amines in the Salmonella mutagenicity assay.
Dashwood RH; Breinholt V; Bailey GS
Carcinogenesis; 1991 May; 12(5):939-42. PubMed ID: 1903094
[TBL] [Abstract][Full Text] [Related]
8. Mutagenicity and cytotoxicity of the carcinogen-mutagen aflatoxin B1 in Streptococcus pneumoniae (Pneumococcus) and Salmonella typhimurium: dependence on DNA repair functions.
Stark AA; Giroux CN
Mutat Res; 1982 Dec; 106(2):195-208. PubMed ID: 6818473
[TBL] [Abstract][Full Text] [Related]
9. Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish.
Bailey GS; Williams DE; Wilcox JS; Loveland PM; Coulombe RA; Hendricks JD
Carcinogenesis; 1988 Nov; 9(11):1919-26. PubMed ID: 3141073
[TBL] [Abstract][Full Text] [Related]
10. Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems.
Denissenko MF; Cahill J; Koudriakova TB; Gerber N; Pfeifer GP
Mutat Res; 1999 Apr; 425(2):205-11. PubMed ID: 10216213
[TBL] [Abstract][Full Text] [Related]
11. In vivo treatment with aflatoxin B1 increases DNA oxidation, base excision repair activity and 8-oxoguanine DNA glycosylase 1 levels in mouse lung.
Guindon-Kezis KA; Mulder JE; Massey TE
Toxicology; 2014 Jul; 321():21-6. PubMed ID: 24675474
[TBL] [Abstract][Full Text] [Related]
12. Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the rat.
Mandel HG; Manson MM; Judah DJ; Simpson JL; Green JA; Forrester LM; Wolf CR; Neal GE
Cancer Res; 1987 Oct; 47(19):5218-23. PubMed ID: 2887284
[TBL] [Abstract][Full Text] [Related]
13. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.
Forrester LM; Neal GE; Judah DJ; Glancey MJ; Wolf CR
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8306-10. PubMed ID: 2122459
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa.
Wojnowski L; Turner PC; Pedersen B; Hustert E; Brockmöller J; Mendy M; Whittle HC; Kirk G; Wild CP
Pharmacogenetics; 2004 Oct; 14(10):691-700. PubMed ID: 15454734
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization of the major adducts obtained after reaction of an ultimate carcinogen aflatoxin B1-dichloride with calf thymus DNA in vitro.
Wood ML; Smith JR; Garner RC
Cancer Res; 1988 Oct; 48(19):5391-6. PubMed ID: 3138022
[TBL] [Abstract][Full Text] [Related]
16. Metabolism, covalent binding, and mutagenicity of aflatoxin B1 by liver extracts from rats of various ages.
Jayaraj A; Hardwick JP; Diller TW; Richardson AG
J Natl Cancer Inst; 1985 Jan; 74(1):95-103. PubMed ID: 3918213
[TBL] [Abstract][Full Text] [Related]
17. Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer.
Guengerich FP; Johnson WW; Ueng YF; Yamazaki H; Shimada T
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):557-62. PubMed ID: 8781383
[TBL] [Abstract][Full Text] [Related]
18. DNA replication-blocking properties of adducts formed by aflatoxin B1-2,3-dichloride and aflatoxin B1-2,3-oxide.
Jacobsen JS; Refolo LM; Conley MP; Sambamurti K; Humayun MZ
Mutat Res; 1987 Jul; 179(1):89-101. PubMed ID: 3110609
[TBL] [Abstract][Full Text] [Related]
19. Immunological detection of aflatoxin B1-DNA adducts formed in vivo.
Hsieh LL; Hsu SW; Chen DS; Santella RM
Cancer Res; 1988 Nov; 48(22):6328-31. PubMed ID: 3141043
[TBL] [Abstract][Full Text] [Related]
20. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
